Daniel Rotrosen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Daniel Rotrosen has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Alkis Togias
National Institute of Allergy and Infectious Diseases, Bethesda, MD
2 shared publications - Antonella Muraro
Food Allergy Referral Centre, Veneto Region, Department of Women’s and Children’s Health, Padua University Hospital, 35128 Padua, Italy
2 shared publications - David R. Stukus
Section of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus, Ohio
2 shared publications - Edmond S. Chan
Division of Allergy, Department of Pediatrics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada; BC Children's Hospital Research Institute, Vancouver, BC, Canada
2 shared publications - Hugh A. Sampson
Icahn School of Medicine at Mount Sinai Department of Pediatrics
2 shared publications - Jonathan Michael Spergel
Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
2 shared publications
Latest Publications
- 1 March 2017
- Published by Wolters Kluwer Health in JAAPA
- Vol. 30 (3) , 1-5
Addendum guidelines for the prevention of peanut allergy in the United States
- 1 March 2017
- Published by Wolters Kluwer Health in JAAPA
- Vol. 30 (3) , 1-5
Addendum guidelines for the prevention of peanut allergy in the United States
- Open Access
- 6 January 2017
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 13 (1) , 1
Addendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel
Food allergy is an important public health problem because it affects children and adults, can be severe and even life-threatening, and may be increasing in prevalence. Beginning in 2008, the National Institute of Allergy and Infectious Diseases, working with other organizations and advocacy groups, led the development of the first clinical guidelines for the diagnosis and management of food allergy. A recent landmark clinical trial and other emerging data suggest that peanut allergy can be prevented through introduction of peanut-containing foods beginning in infancy. Prompted by these findings, along with 25 professional organizations, federal agencies, and patient advocacy groups, the National Institute of Allergy and Infectious Diseases facilitated development of addendum guidelines to specifically address the prevention of peanut allergy. The addendum provides 3 separate guidelines for infants at various risk levels for the development of peanut allergy and is intended for use by a wide variety of health care providers. Topics addressed include the definition of risk categories, appropriate use of testing (specific IgE measurement, skin prick tests, and oral food challenges), and the timing and approaches for introduction of peanut-containing foods in the health care provider’s office or at home. The addendum guidelines provide the background, rationale, and strength of evidence for each recommendation. Guidelines have been developed for early introduction of peanut-containing foods into the diets of infants at various risk levels for peanut allergy.
- 6 January 2017
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 13 (1) , 1
Open AccessAddendum guidelines for the prevention of peanut allergy in the United States: report of the National Institute of Allergy and Infectious Diseases-sponsored expert panel
Food allergy is an important public health problem because it affects children and adults, can be severe and even life-threatening, and may be increasing in prevalence. Beginning in 2008, the National Institute of Allergy and Infectious Diseases, working with other organizations and advocacy groups, led the development of the first clinical guidelines for the diagnosis and management of food allergy. A recent landmark clinical trial and other emerging data suggest that peanut allergy can be prevented through introduction of peanut-containing foods beginning in infancy. Prompted by these findings, along with 25 professional organizations, federal agencies, and patient advocacy groups, the National Institute of Allergy and Infectious Diseases facilitated development of addendum guidelines to specifically address the prevention of peanut allergy. The addendum provides 3 separate guidelines for infants at various risk levels for the development of peanut allergy and is intended for use by a wide variety of health care providers. Topics addressed include the definition of risk categories, appropriate use of testing (specific IgE measurement, skin prick tests, and oral food challenges), and the timing and approaches for introduction of peanut-containing foods in the health care provider’s office or at home. The addendum guidelines provide the background, rationale, and strength of evidence for each recommendation. Guidelines have been developed for early introduction of peanut-containing foods into the diets of infants at various risk levels for peanut allergy.
- 1 February 2014
- Published by Elsevier in Clinical Immunology
- Vol. 150 (2) , A1-A2
Lloyd Mayer, MD, 1952–2013, In Memoriam
- 1 February 2014
- Published by Elsevier in Clinical Immunology
- Vol. 150 (2) , A1-A2
Lloyd Mayer, MD, 1952–2013, In Memoriam
- 1 January 2007
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 119 (1) , 258-262
The National Institute of Allergy and Infectious Diseases' asthma research programs: A retrospective
- 1 January 2007
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 119 (1) , 258-262
The National Institute of Allergy and Infectious Diseases' asthma research programs: A retrospective